ReportGemReportGem 中文

PUBLIC COMPANY RESEARCH HUB

COLGATE PALMOLIVE CO (CL) Filings, Earnings Calls and Research

A source-backed research workspace for COLGATE PALMOLIVE CO. Compare recent disclosures, management commentary and foreign research coverage without losing the original evidence trail.

Evidence documents7
Filings7
Meetings0
Research0
Displayed research share0%
Latest evidence2026-07-31

Primary-source evidence

10-Q2026-07-31 · SEC EDGAR · 10-Q

Colgate-Palmolive reported Q2 2026 net sales of $5,361 million, up 4.9% YoY, with organic sales growth of 2.4%. GAAP gross margin improved to 61.5% from 60.1%. GAAP net income attributable to company was $693 million, down from $743 million, while adjusted net…

8-K2026-05-01 · SEC EDGAR · 8-K

Colgate-Palmolive announced on April 30, 2026 an expansion of its Strategic Growth and Productivity Program, increasing estimated cumulative pre-tax charges to $350-$550 million from $200-$300 million.…

10-Q2026-05-01 · SEC EDGAR · 10-Q

Colgate-Palmolive reported Q1 2026 net sales of $5,324 million, up 8.4% year-over-year, but GAAP operating profit fell 10% to $964 million due to Strategic Growth and Productivity Program charges.…

8-K2026-03-17 · SEC EDGAR · 8-K

Colgate-Palmolive filed an 8-K on March 17, 2026, announcing a realignment of reportable operating segments effective Q1 2026. Europe and Africa/Eurasia (ex-Russia/Belarus) plus Skin Health (from North America) form a new Europe, Middle East and Africa segment…

10-K2026-02-23 · SEC EDGAR · 10-K

Colgate-Palmolive's 2025 net sales increased, but GAAP net income fell due to a $794 million after-tax impairment of skin health goodwill and intangibles and ERISA litigation charges. Non-GAAP EPS rose 3% to $3.69.…

8-K2025-10-31 · SEC EDGAR · 8-K

Colgate-Palmolive filed an 8-K on October 31, 2025, reporting Q3 earnings and disclosing a new three-year productivity program approved by the Board on July 31, 2025. The program is expected to incur $200-$300 million in pre-tax charges, primarily for employee…

10-Q2025-10-31 · SEC EDGAR · 10-Q

Colgate-Palmolive reported Q3 2025 net sales of $5,131 million, up 2.0% YoY, with organic sales growth of 0.4%. Gross margin declined to 59.4% due to higher raw material costs. Net income was $735 million, and diluted EPS was $0.91, flat YoY.…

Questions this evidence can help answer

  • What changed in the latest research coverage of COLGATE PALMOLIVE CO?
  • Which operating and valuation themes recur across institutions?
  • Which claims should be checked against company primary-source evidence?
Research this company with AI